期刊文献+

医院获得性肺炎的定义和诊治 被引量:6

Definition,diagnosis and treatment of hospital-acquired pneumonia
下载PDF
导出
摘要 医院获得性肺炎(Hospital-Acquired Pneumonia,HAP)是全球性的公共卫生问题。据不同报告,HAP发病率在0.1%-2.1%不等,相关死亡率约25%-54%;呼吸机相关性肺炎fVentilator-Associated Pneumonia,VAP)在气管插管患者中的发病率约9%-27%,死亡率约24%-50%,多重耐药菌感染者死亡率更高[14]。我国目前尚无全国多中心大样本的发病率和死亡率报告,但从现有研究看,我国HAP和VAP的发病率与国外报告接近。
作者 周庆涛 贺蓓
出处 《军医进修学院学报》 CAS 2011年第7期682-683,697,共3页 Academic Journal of Pla Postgraduate Medical School
  • 相关文献

参考文献23

  • 1American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia [ S ] . Am J Respir Crit Care Med, 2005, 171 ( 4 ) : 388-416.
  • 2Masterton RG, Galloway A, French G, et al. Gmdehnes tor me management of hospital-acquired pneumonia in the UK : report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy [ S ] . J Antimicrob Chemother, 2008, 62 (1): 5-34.
  • 3Chawla R. Epidemiology, etiology, and diagnosis of hospital- acquired pneumonia and ventilator-associated pneumonia in Asiancountries [ J ] . Am J Infect Control, 2008, 36 ( 4 Suppl ) : S93-S100.
  • 4Song JH; Asian Hospital Acquired Pneumonia Working Group. Treatment recommendations of hospital-acquired pneumonia in Asian countries : first consensus report by the Asian HAP Working Group [ S ] . Am J Infect Control, 2008, 36 ( 4 Suppl ) : S83-S92.
  • 5Torres A, Ewig S, Lode H, et al. Defining, treating and preventing hospital acquired pneumonia : European perspective [ S ] . Intensive Care Med, 2009, 35 ( 1 ) : 9-29.
  • 6Joseph NM, Sistla S, Dutta TK, et al. Ventilator-associated pneumonia in a tertiary care hospital in India : incidence and risk factors [ J ] . J Infect Dev Ctries, 2009, 3 ( 10 ) : 771-777.
  • 7Safdar N, Crnich C J, Maki DG. The pathogenesis of ventilator- associated pneumonia : its relevance to developing effective strategies for prevention [ J ] . Respir Care, 2005, 50 ( 6 ) : 725-739.
  • 8医院获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):201-208. 被引量:2163
  • 9Giantsou E, Liratzopoulos N, Efraimidou E, et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria [ J ] . Intensive Care Med, 2005, 31 ( 11 ) : 1488-1494.
  • 10Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting [ S ] . Am J Infect Control, 2008, 36 (5) : 309-332.

二级参考文献52

  • 1刘明华,张庆玲,府伟灵.呼吸机相关性肺炎的流行病学和诊断进展[J].中华医院感染学杂志,2004,14(1):116-118. 被引量:266
  • 2蔡少华,张进川,俞森洋,刘长庭,钱桂生.呼吸机相关肺炎的病原学和耐药性监测[J].中华医院感染学杂志,2004,14(4):365-368. 被引量:98
  • 3Rhomberg P R, Jones R N. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: Report from the MYSTIC Program (2002) in North America[J]. Diagn Microbiol Infect Dis, 2003, 47( 1 ): 365 -372.
  • 4Conte J E, Golden J A, Kelley M G, et al. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem[J]. Int J Antimicrob Agents, 2005, 26(6): 449 -456.
  • 5Abo EI-Sooud K. Plasma pharmacokinetics and urine concentrations of meropenem in ewes[J] . J Vet Pharmacol Ther, 2004, 27 ( 1 ) : 27 - 30.
  • 6Fish D N, Singletary T J. Meropenem, a new carbapenem antibiotic[J]. Pharmacotherapy, 1997, 17(4): 644 - 669.
  • 7Turnidge J D. The pharmacodynamics of beta-lactams[J]. Clin Infect Dis, 1998, 27(1): 10~22.
  • 8Drusano G L. Prevention of resistance: A goal for dose selection of antimlcrobial agents[J]. Clin Infect Dis, 2003, 36 (Suppl 1 ): s42 - s50.
  • 9Bustamente C I, Drusano G L, Tatem B A, et al. Postantibiotic effect of imipenem on Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1984, 26 (5) : 678 - 682.
  • 10Lowe M N, lamb H M. Meropenem: an updated review of its use in the management of intra-abdominal infections[J]. Drugs, 2000, 60(3):619-646.

共引文献2278

同被引文献95

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部